← Back to Clinical Trials
Recruiting NCT05964010

NCT05964010 Primary Connections for Youth and Families

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05964010
Status Recruiting
Phase —
Sponsor The National Center on Addiction and Substance Abuse at Columbia University
Condition Substance Use
Study Type INTERVENTIONAL
Enrollment 2,300 participants
Start Date 2024-03-01
Primary Completion 2028-11

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Standard ScreeningStandard PsychoeducationStandard Brief Negotiated Interview (BNI)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 2,300 participants in total. It began in 2024-03-01 with a primary completion date of 2028-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to compare a standard adolescent-only approach to substance use screening, brief intervention, and referral to treatment to a in primary care settings. Primary outcomes (AOD use, co-occurring behavior problems, parent-youth communication about AOD use) and secondary outcomes (adolescent quality of life, therapy attendance) are assessed at screen/initial and 3, 6, 9, and 12 months follow-up.

Eligibility Criteria

Inclusion Criteria: * Youth aged 12-17 years with a primary caregiver (i.e., parental figure) also in attendance to primary care appointment * Youth and caregiver are fluent in English or Spanish * Youth and caregiver are capable of using audio-assisted informed consent procedures and independently operating a hand-held tablet device * Youth and caregiver are complete routine site AOD risk screening questions prompted during PC visit intake

Contact & Investigator

Central Contact

Nicole P Porter, PhD

✉ nporter@toendaddiction.org

📞 212-841-5265

Principal Investigator

Aaron Hogue, PhD

PRINCIPAL INVESTIGATOR

Partnership to End Addiction

Frequently Asked Questions

Who can join the NCT05964010 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 17 Years, studying Substance Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05964010 currently recruiting?

Yes, NCT05964010 is actively recruiting participants. Contact the research team at nporter@toendaddiction.org for enrollment information.

Where is the NCT05964010 trial being conducted?

This trial is being conducted at New York, United States.

Who is sponsoring the NCT05964010 clinical trial?

NCT05964010 is sponsored by The National Center on Addiction and Substance Abuse at Columbia University. The principal investigator is Aaron Hogue, PhD at Partnership to End Addiction. The trial plans to enroll 2,300 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology